Patents by Inventor Daniel Ricquier

Daniel Ricquier has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of a retinoid type compound to modulate in vivo the decoupling activity of the protein UCP2
    Publication number: 20030229143
    Abstract: The invention relates to the use of a compound of the retinoid type particularly retinoid acid for the preparation of a medicament capable of modulating in vivo the decoupling activity of decoupling proteins. These compounds can be used conveniently for the treatment of diseases associated to an increase or reduction of the activity of decoupling proteins. According to a preferred embodiment, the retinoid acid will be used for the treatment of disease associate to a reduction of the decoupling activity of the protein UCP2 such as for example obesity.
    Type: Application
    Filed: January 16, 2003
    Publication date: December 11, 2003
    Inventors: Frederic Bouillaud, Daniel Ricquier, Eduardo Rial Zueco
  • Respiration uncoupling protein
    Publication number: 20030119775
    Abstract: The present invention relates, in general, to a protein linked to cell respiration, thermogenesis, obesity and hyperinsulinemia and, in particular, to a protein designated uncoupling protein-2 (UCP2) and to nucleic acid sequences encoding same. The invention also relates to diagnostic methodologies based, for example, on a determination of levels of UCP2 expression. Further, the invention relates to therapies involving modulating UCP2 expression and/or activity. In addition, the present invention relates to methods of screening compounds for their suitability for use in such therapies.
    Type: Application
    Filed: October 8, 2002
    Publication date: June 26, 2003
    Applicants: DUKE UNIVERSITY, REGENTS OF THE UNIVERSITY OF CALIFORNIA, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
    Inventors: Richard S. Surwit, Sheila A. Collins, Craig H. Warden, Michael F. Seldin, Daniel Ricquier, Frederic Bouillaud
  • Use of a retinoid type compound to modulate in vivo the decoupling activity of the protein UCP2
    Publication number: 20020165280
    Abstract: The invention relates to the use of a compound of the retinoid type particularly retinoid acid for the preparation of a medicament capable of modulating in vivo the decoupling activity of decoupling proteins. These compounds can be used conveniently for the treatment of diseases associated to an increase or reduction of the activity of decoupling proteins. According to a preferred embodiment, the retinoid acid will be used for the treatment of disease associate to a reduction of the decoupling activity of the protein UCP2 such as for example obesity.
    Type: Application
    Filed: January 7, 2002
    Publication date: November 7, 2002
    Inventors: Frederic Bouillaud, Daniel Ricquier, Eduardo Rial Zueco